• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高血压伴心房颤动患者心脏重构标志物的新关联模式。

Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.

机构信息

Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.

出版信息

BMC Cardiovasc Disord. 2011 Dec 28;11:77. doi: 10.1186/1471-2261-11-77.

DOI:10.1186/1471-2261-11-77
PMID:22204652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3276440/
Abstract

BACKGROUND

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are essential for the cardiac extracellular matrix (ECM) remodeling. We investigated differences in serum levels of these markers between patients with atrial fibrillation (AF) and sinus rhythm (SR).

METHODS

Serum levels of MMP-2, MMP-3, MMP-9 and TIMP-1 were measured in 86 patients: 27 on SR without any AF history, 33 with paroxysmal and 26 with permanent AF. All subjects had essential hypertension, normal systolic function and no coronary artery disease.

RESULTS

Patients with AF had higher MMP-2, MMP-3 and MMP-9 and lower TIMP-1 compared to SR subjects (all p < 0.001). Paroxysmal AF was associated with higher MMP-2 levels compared to permanent AF (p < 0.001). Matrix metalloproteinase-9 but not MMP-3 was higher in permanent compared to paroxysmal AF group (p < 0.001). Patients with AF had lower levels of TIMP-1 compared to those with SR while permanent AF subjects had lower TIMP-1 levels than those with paroxysmal AF (p < 0.001 for both comparisons). Lower TIMP-1 was the only independent factor associated with AF (OR: 0.259, 95%CI: 0.104-0.645, p = 0.004).

CONCLUSIONS

In hypertensives, paroxysmal AF and permanent AF differ with respect to serum MMPs. Increased MMP-2 is associated with paroxysmal, whereas increased MMP-9 with permanent AF. Additionally, lower levels of TIMP-1 had a strong association with AF incidence.

摘要

背景

基质金属蛋白酶(MMPs)及其组织抑制剂(TIMPs)对于心脏细胞外基质(ECM)的重塑至关重要。我们研究了在心房颤动(AF)和窦性节律(SR)患者之间这些标志物的血清水平差异。

方法

在 86 名患者中测量了 MMP-2、MMP-3、MMP-9 和 TIMP-1 的血清水平:27 名处于 SR 且无任何 AF 病史,33 名患有阵发性 AF,26 名患有永久性 AF。所有患者均患有原发性高血压、正常收缩功能且无冠心病。

结果

与 SR 患者相比,AF 患者的 MMP-2、MMP-3 和 MMP-9 水平更高,TIMP-1 水平更低(均 p < 0.001)。与永久性 AF 相比,阵发性 AF 患者的 MMP-2 水平更高(p < 0.001)。与阵发性 AF 相比,永久性 AF 患者的 MMP-9 水平更高(p < 0.001)。与 SR 患者相比,AF 患者的 TIMP-1 水平更低,而与阵发性 AF 相比,永久性 AF 患者的 TIMP-1 水平更低(两种比较均 p < 0.001)。TIMP-1 水平较低是与 AF 相关的唯一独立因素(OR:0.259,95%CI:0.104-0.645,p = 0.004)。

结论

在高血压患者中,阵发性 AF 和永久性 AF 之间在血清 MMPs 方面存在差异。MMP-2 与阵发性 AF 相关,而 MMP-9 与永久性 AF 相关。此外,TIMP-1 水平较低与 AF 发生率有很强的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/62b94f69febd/1471-2261-11-77-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/fd82423bf86d/1471-2261-11-77-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/2794103b405a/1471-2261-11-77-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/62b94f69febd/1471-2261-11-77-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/fd82423bf86d/1471-2261-11-77-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/2794103b405a/1471-2261-11-77-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edad/3276440/62b94f69febd/1471-2261-11-77-3.jpg

相似文献

1
Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.原发性高血压伴心房颤动患者心脏重构标志物的新关联模式。
BMC Cardiovasc Disord. 2011 Dec 28;11:77. doi: 10.1186/1471-2261-11-77.
2
The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.纤溶酶原激活物抑制物-1 在阵发性和持续性心房颤动中的作用。
Cytokine. 2018 Mar;103:63-68. doi: 10.1016/j.cyto.2017.12.026. Epub 2018 Jan 8.
3
MMP-9 in atrial remodeling in patients with atrial fibrillation.基质金属蛋白酶-9在心房颤动患者心房重构中的作用
Ann Cardiol Angeiol (Paris). 2015 Sep;64(4):285-91. doi: 10.1016/j.ancard.2014.12.004. Epub 2015 Jan 30.
4
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.二尖瓣疾病和心房颤动患者中的基质金属蛋白酶与心房重构
Cardiovasc Res. 2005 Sep 1;67(4):655-66. doi: 10.1016/j.cardiores.2005.04.016.
5
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?心房颤动中的血栓形成与基质金属蛋白酶-1及其抑制剂金属蛋白酶组织抑制因子-1有关吗?
Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27.
6
[Changes in gelatinases expression and activity in human atria during atrial fibrillation].[心房颤动时人心房明胶酶表达及活性的变化]
Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):137-42.
7
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.基质金属蛋白酶/金属蛋白酶组织抑制剂:基质成分蛋白水解决定因素的变化与高血压性心脏病的结构、功能及临床表现之间的关系
Circulation. 2006 May 2;113(17):2089-96. doi: 10.1161/CIRCULATIONAHA.105.573865. Epub 2006 Apr 24.
8
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.高血压患者体内的基质金属蛋白酶-2、-9及金属蛋白酶组织抑制剂-1
Endothelium. 2006 May-Jun;13(3):227-31. doi: 10.1080/10623320600780942.
9
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.病例-队列研究中血浆基质金属蛋白酶-9与新发心房颤动风险的新关联:社区动脉粥样硬化风险研究。
PLoS One. 2013;8(3):e59052. doi: 10.1371/journal.pone.0059052. Epub 2013 Mar 15.
10
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.基质金属蛋白酶-9在心房颤动期间对人类心房重构有促进作用。
J Am Coll Cardiol. 2004 Mar 3;43(5):818-25. doi: 10.1016/j.jacc.2003.08.060.

引用本文的文献

1
The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation.主要炎症生物标志物在心房颤动发病机制中的作用
J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5265-5277. doi: 10.19102/icrm.2022.13125. eCollection 2022 Dec.
2
Cardiac arrhythmias in arterial hypertension.动脉高血压中的心律失常。
J Clin Hypertens (Greenwich). 2020 Aug;22(8):1371-1378. doi: 10.1111/jch.13989. Epub 2020 Aug 9.
3
Preoperative Antihypertensive Medication in Relation to Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: A Meta-Analysis.

本文引用的文献

1
Clinical disorders of the heart beat.心跳的临床紊乱。
Clinics. 1946 Jun;5(1):190-234.
2
Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.高血压与阵发性心房颤动:超敏 C 反应蛋白在转复及长期复发中的新预测作用
J Hum Hypertens. 2010 Jul;24(7):447-57. doi: 10.1038/jhh.2009.89. Epub 2010 Jan 14.
3
Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
心脏手术患者术前抗高血压药物与术后心房颤动的关系:一项荟萃分析
Biomed Res Int. 2017;2017:1203538. doi: 10.1155/2017/1203538. Epub 2017 Feb 13.
4
The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.血清基质金属蛋白酶-9水平是持续性心房颤动消融术后复发的独立预测指标。
Clinics (Sao Paulo). 2016 May;71(5):251-6. doi: 10.6061/clinics/2016(05)02.
5
MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese.基质金属蛋白酶9(MMP9)基因rs3918242多态性影响培养的心房来源心肌细胞中由心动过速诱导的MMP9表达,但并非台湾人心房颤动的危险因素。
Int J Mol Sci. 2016 Apr 7;17(4):521. doi: 10.3390/ijms17040521.
6
Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.电生理学中的生物标志物:在心律失常和再同步治疗中的作用。
J Interv Card Electrophysiol. 2015 Jun;43(1):31-44. doi: 10.1007/s10840-015-9982-7. Epub 2015 Feb 27.
7
Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.预测术后房颤的循环生物标志物
Cardiol Rev. 2016 Mar-Apr;24(2):76-87. doi: 10.1097/CRD.0000000000000059.
8
[Retroperitoneal fibrosis: development of a biomarker profile for diagnosis and therapy monitoring].[腹膜后纤维化:用于诊断和治疗监测的生物标志物谱的开发]
Urologe A. 2015 Jan;54(1):52-61. doi: 10.1007/s00120-014-3713-z.
9
Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.用于评估非瓣膜性心房颤动左心房重构的新型纤维炎症标志物
Med Sci Monit. 2014 Mar 21;20:463-70. doi: 10.12659/MSM.890635.
10
Cardioembolic stroke diagnosis using blood biomarkers.使用血液生物标志物诊断心源性栓塞性卒中。
Curr Cardiol Rev. 2013 Nov;9(4):340-52. doi: 10.2174/1573403x10666140214122633.
快速心房起搏诱导的心房颤动中基质金属蛋白酶-9和金属蛋白酶组织抑制剂的上调
J Mol Cell Cardiol. 2008 Dec;45(6):742-53. doi: 10.1016/j.yjmcc.2008.07.007. Epub 2008 Jul 23.
4
Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.阵发性和持续性心房颤动患者的细胞外基质改变:I型胶原周转的生化评估
J Am Coll Cardiol. 2008 Jul 15;52(3):211-5. doi: 10.1016/j.jacc.2008.03.045.
5
Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation.心房颤动中心房纤维化重塑的调节机制
Cell Mol Life Sci. 2008 May;65(10):1489-508. doi: 10.1007/s00018-008-7408-8.
6
Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome.近期发作的心房颤动患者白细胞介素-2血清水平变化与复律结果相关。
Cytokine. 2007 Dec;40(3):157-64. doi: 10.1016/j.cyto.2007.08.013. Epub 2007 Oct 17.
7
Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure.心力衰竭期间,纤维化的空间分布决定了左心房后壁的颤动波动态。
Circ Res. 2007 Oct 12;101(8):839-47. doi: 10.1161/CIRCRESAHA.107.153858. Epub 2007 Aug 17.
8
Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.随着人类心房颤动持续时间的增加,纤溶酶原激活物抑制剂和组织金属蛋白酶抑制剂表达的降低可能会促进金属蛋白酶活性的增加。
J Cardiovasc Electrophysiol. 2007 Sep;18(10):1076-82. doi: 10.1111/j.1540-8167.2007.00906.x. Epub 2007 Jul 26.
9
Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKCalpha/beta1 and MAPKs.白细胞介素-1β增加心脏微血管内皮细胞中基质金属蛋白酶-2的表达和活性:蛋白激酶Cα/β1和丝裂原活化蛋白激酶的作用。
Am J Physiol Cell Physiol. 2007 Feb;292(2):C867-75. doi: 10.1152/ajpcell.00161.2006. Epub 2006 Sep 20.
10
Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB.心脏缺血再灌注损伤通过AP-1成分FosB和JunB诱导基质金属蛋白酶-2表达。
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1838-46. doi: 10.1152/ajpheart.00026.2006. Epub 2006 May 12.